Belgium
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 839.95 M
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
USD 469.93 M
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
3 |
USD 241.94 M
|
Dec. 31, 2023 | USD 19.81 | 0.71% |
|
Belgium |
|
4 |
USD -2.26 M
|
Dec. 31, 2023 | USD 150.68 | -0.48% |
|
Belgium |
|
5 |
USD -20.18 M
|
Dec. 31, 2023 | USD 3.28 | -5.91% |
|
Belgium |
|
6 |
USD -21.82 M
|
Dec. 31, 2023 | USD 13.71 | -0.44% |
|
Belgium |
|
7 |
USD -448.09 M
|
Dec. 31, 2023 | USD 24.20 | -0.41% |
|
Belgium |
The Biotechnology company in Belgium with the highest Operating Cash Flow is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 839.95 M.
The Biotechnology company in Belgium with the lowest Operating Cash Flow is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at USD -448.09 M.
The top 10 Biotechnology companies in Belgium by Operating Cash Flow are UCB SA, Azelis Group NV, Tessenderlo Group NV, Financière de Tubize SA, Biotalys NV, Ion Beam Applications SA and Galapagos NV.
The bottom 10 Biotechnology companies in Belgium by Operating Cash Flow are Galapagos NV, Ion Beam Applications SA, Biotalys NV, Financière de Tubize SA, Tessenderlo Group NV, Azelis Group NV and UCB SA.